Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Aspirin × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 26 Colonic Neoplasms 12 Neoplasms 11 Breast Neoplasms 11 Prostatic Neoplasms 8 Polycythemia Vera 8 Venous Thromboembolism 7 Recurrence 6 Multiple Myeloma 6 Rectal Neoplasms 5 Ovarian Neoplasms 4 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Esophageal Neoplasms 4 Cardiovascular Diseases 4 Carcinoma, Non-Small-Cell Lung 4 Barrett Esophagus 4 Thrombocythemia, Essential 3 Stomach Neoplasms 3 Precancerous Conditions 3 Melanoma 3 Gastrointestinal Neoplasms 3 Adenomatous Polyps 3 Adenoma 3 Thrombosis 2 Thromboembolism 2 Smoking Cessation 2 Sarcoma 2 Primary Myelofibrosis 2

Interventions

Exercise 23 Metformin 18 Tirzepatide 8 Diet 8 Resistance Training 7 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 7 Early Intervention, Educational 6 Caloric Restriction 6 semaglutide 5 Exenatide 5 Diet, Mediterranean 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Docosahexaenoic Acids 4 Bariatric Surgery 4 exemestane 3 Vitamin D 3 Therapeutics 3 Tamoxifen 3 Standard of Care 3 Observation 3 Naltrexone 3 Letrozole 3 Dexamethasone 3 Bupropion 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡